A medical fluid control device includes an actuator that is selectively operable to cause a fluid to be delivered from a fluid source to a patient at a basal rate of flow via a first flow path, or cause a bolus dose of the fluid to be delivered from a bolus reservoir to the patient via a second flow path.
|
18. A device for controlling delivery of a fluid from a fluid source to a patient, the device comprising:
a first flow path between the fluid source and the patient, the first flow path for delivering the fluid from the fluid source to the patient at a basal rate of flow;
a second flow path between the fluid source and the patient, the second flow path including:
a bolus reservoir;
a bolus valve disposed between the bolus reservoir and the patient;
a first branch including a bolus restrictor tubing in which the fluid source is in fluid communication at a bolus filling rate with the bolus reservoir and the bolus valve; and
a second branch including a branch valve, and not including the bolus restrictor tubing, in which the fluid source is in fluid communication with the bolus reservoir and the bolus valve; and
an actuator that is selectively rotatable to place the device in each of the following modes:
a priming mode in which, when selected by the actuator, the actuator opens the bolus valve and the branch valve and the fluid flows through the first flow path, the first branch of the second flow path, and the second branch of the second flow path;
a fill mode in which, when selected by the actuator, the actuator closes the bolus valve, opens the branch valve, and the fluid flows from the fluid source to the bolus reservoir via the second branch of the second flow path; and
a standby mode in which, when selected by the actuator, the actuator closes the bolus valve and the branch valve and the fluid flows between the fluid source and the patient via the first flow path.
15. A method for controlling delivery of a fluid from a fluid source to a patient using a device having a first flow path and a second flow path parallel to the first flow path, the method comprising:
providing the fluid at a basal rate of flow to the patient via the first flow path;
providing the fluid at a bolus filling rate of flow to a bolus reservoir via a bolus restrictor tube located within a first branch of the second flow path;
actuating a bolus valve and a branch valve with a single actuator to operably select each of at least three modes of operation, the at least three modes of operation including a priming mode, a fill mode, and a standby mode:
the priming mode selected by the actuator opening the bolus valve and the branch valve such that the fluid flows through the first flow path, the first branch of the second flow path, and a second branch of the second flow path;
the fill mode selected by the actuator closing the bolus valve and opening the branch valve such that the fluid flows from the fluid source to the bolus reservoir via the second branch of the second flow path;
the standby mode selected by the actuator closing the bolus valve and the branch valve such that the fluid flows between the fluid source and the patient via the first flow path; and
in response to actuation of the bolus valve by the actuator, delivering a bolus dose of the fluid to the patient via the second flow path, the bolus dose being provided by opening with the actuator the bolus valve to release the bolus dose from the bolus reservoir, the bolus valve disposed along the second flow path.
1. A device for controlling delivery of a fluid from a fluid source to a patient, the device comprising:
a first flow path between the fluid source and the patient, the first flow path for delivering the fluid from the fluid source to the patient at a basal rate of flow;
a second flow path between the fluid source and the patient, the second flow path including:
a first branch and a second branch;
a bolus reservoir distal to the first branch and the second branch in the second flow path;
a bolus valve disposed between the bolus reservoir and the patient;
the first branch including a bolus restrictor tubing in which the fluid source is in fluid communication at a bolus filling rate with the bolus reservoir and the bolus valve; and
the second branch including a branch valve in which the fluid source is in fluid communication with the branch valve, the bolus reservoir and the bolus valve; and
a single actuator that actuates the bolus valve and the branch valve to operably select each of at least three modes of operation, the at least three modes of operation including a priming mode, a fill mode, and a standby mode:
the priming mode selected by the actuator opening the bolus valve and the branch valve such that the fluid flows through the first flow path, the first branch of the second flow path, and the second branch of the second flow path;
the fill mode selected by the actuator closing the bolus valve and opening the branch valve such that the fluid flows from the fluid source to the bolus reservoir via the second branch of the second flow path; and
the standby mode selected by the actuator closing the bolus valve and the branch valve such that the fluid flows between the fluid source and the patient via the first flow path.
2. The device of
3. The device of
5. The device of
6. The device of
7. The device of
8. The device of
9. The device of
13. The device of
14. The device of
16. The method of
17. The method of
|
The ability of a patient to self-deliver medication, e.g., in offsite therapy or where a nurse or caregiver is not immediately available, offers a solution to logistical issues arising from medical situations such as chronic therapy. Patient-controlled analgesia (PCA) is widely accepted in the field of pain management, as it enables patients to provide themselves with pain relief at times when such relief is most needed. PCA devices ideally include safeguards against overdoses and are easy and safe for a patient with little or no medical training to operate.
PCA devices often allow additional bolus doses of a predetermined amount of medication to be delivered to the patient, for instance when a patient needs or desires additional pain relief. After the bolus dose is delivered, the patient may continue to receive a normal (basal) rate of continuous infusion from an IV pump to which the PCA device is connected. In some cases, the basal rate is zero, meaning that the patient receives medication only when the PCA device is actuated.
In general, in one aspect, the invention features a device for controlling the delivery of a fluid from a fluid source to a patient. The device includes a first flow path between the fluid source and the patient, the first flow path for delivering fluid from the fluid source to the patient at a basal rate of flow; a second flow path between the fluid source and the patient, the second flow path including: a bolus reservoir; a bolus valve disposed between the bolus reservoir and the patient; a first branch in which the fluid source is in fluid communication with the bolus reservoir and the bolus valve; and a second branch in which the fluid source is in fluid communication with a branch valve, the bolus reservoir and the bolus valve; and an actuator that is selectively operable to place the device in one of at the following modes: a priming mode in which the bolus valve and the branch valve are open and fluid flows through the first flow path, the first branch of the second flow path, and the second branch of the second flow path; a fill mode in which the bolus valve is closed and the branch valve is open and fluid flows from the fluid source to the bolus reservoir via the second branch of the second flow path; and a standby mode in which the bolus valve and the branch valve are closed and fluid flows between the fluid source and the patient via the first flow path.
Embodiments of the invention may include one or more of the following features.
In the standby mode, the actuator is selectively further operable to open the branch valve and apply pressure to the bolus reservoir to cause fluid stored in the bolus reservoir to flow to the patient. The actuator may be depressed responsive to user action.
The first flow path may include a basal restrictor tube. The basal restrictor tube may be dimensioned to allow fluid flow through the first flow path at the basal rate of flow.
The device may be configured to allow filling of the bolus reservoir while fluid is being delivered to the patient via the first flow path.
The first branch may include a branch restrictor tube dimensioned to allow fluid flow at a bolus filling rate. The bolus filling rate may be preselected based on a desired amount of time needed to fill the bolus reservoir with fluid from the fluid source via the first branch of the second flow path. In the standby mode, fluid may flow between the fluid source and the bolus reservoir via the first branch of the second flow path until the bolus reservoir is filled.
The device may be further configured to operate in a priming mode in which the bolus valve and the branch valve are open and fluid flows between the fluid source and an output of the device via the first flow path and the second flow path.
The actuator may be rotatable to selective rotatable to place the device in one of at least the following modes: the standby mode, the fill mode, and the bolus infusion mode. The actuator may be configured to be depressed to select the bolus infusion mode.
The bolus valve and the branch valve may be pinch tubes.
The actuator may be further configured to open the branch valve to allow fluid flow between the fluid source and the bolus reservoir.
When the actuator is depressed, pressure may be applied to the bolus reservoir such that fluid stored in the bolus reservoir is expelled.
The actuator may be a knob operable by the patient.
The fluid source may be an infusion pump.
In general, in another aspect, the invention features a method for controlling the delivery of fluid from a fluid source to a patient using a device having a first flow path and a second flow path parallel to the first flow path. The method includes providing fluid to the patient via the first flow path at a basal rate of flow; in response to actuation by an actuator, allowing delivery to the patient of fluid stored in a bolus reservoir disposed along the second flow path.
Embodiments of the invention may include one or more of the following features.
The method of allowing delivery of fluid stored in the bolus reservoir may include opening a bolus valve disposed along the second flow path between the bolus reservoir and the patient. The method may further include filling the bolus reservoir with fluid from the fluid source while fluid is being provided to the patient via the first flow path. The method of filling the bolus reservoir may include providing fluid flow from the fluid source to the bolus reservoir via a first branch of the second flow path. The method of filling the bolus reservoir may include providing fluid flow from the fluid source to the bolus reservoir via a second branch of the second flow path. The method of providing fluid flow via the second branch of the second flow path may include opening a branch valve disposed along the second branch.
The infusion control device described herein has a number of advantages. The patient receiving medication can receive continuous infusion of medication and can self-deliver a bolus dose as needed without the danger of an accidental or intentional overdose.
Priming and filling of the bolus reservoir is rapid and efficient. The basal flow rate of fluid or medication to the patient remains constant even when the bolus is being refilled immediately after bolus administration.
The actuator knob has a simple design with a dual function, allowing both quick priming and an initial rapid fill of the bolus in additional to ordinary bolus dose administration.
Other features and advantages of the invention are apparent from the following description and from the claims.
Referring to
Infusion control device 10 is formed of a bottom housing 21 and a top housing 22, within which is disposed an actuator knob 51. Knob 51 is rotatable about a central vertical axis to allow the selection of a particular fluid pathway through the device corresponding to a desired mode of operation (e.g., basal flow rate, bolus administration, or priming and/or filling of the bolus reservoir). Knob 51 is stabilized by guides 221, 222, which help to maintain the position of the knob.
Referring to
To prime infusion control device 10 prior to its initial use, knob 51 is rotated to a position at which valves 31 and 32 are both opened, allowing fluid to flow through all three available flow paths 35, 36, and 37. During priming, both restrictor tubes 33 and 34 and bolus reservoir 30 are inundated with fluid, allowing priming to take place rapidly. In particular, the opening of valve 31 provides a low-resistance pathway between pump 100 and bolus reservoir 30 that avoids restrictor tubes 33, 34. In some embodiments, to further facilitate rapid priming, the bolus reservoir is provided in a deflated state prior to the first use of the infusion control device, minimizing the volume of air that must be expelled from the reservoir prior to filling. In some embodiments, rotation of the knob 51 to a position at which valves 31 and 32 are both opened has the further effect of causing the bolus reservoir to be deflated and held in a deflated state so that the fluid that flows through flow paths 36 and 37 does not accumulate in the bolus reservoir.
To deliver the basal rate of fluid flow, knob 51 is rotated to a position at which both valves 31 and 32 are closed. In this configuration, fluid flows only along basal flow path 35. The size of flow restrictor tube 33 is selected to achieve the desired basal flow rate.
To deliver a bolus dose, knob 51 is rotated to a “ready” position at which only valve 32 is opened. When the knob is depressed, the bottom of the knob exerts pressure on bolus reservoir 30, deflating the reservoir and ejecting the contents. The bolus dose flows via tubing sections 3034 and 3043 to output node 304 and is delivered to the patient 12.
Once a bolus dose has been delivered, knob 51 is rotated to close valve 32 and to allow delivery of fluid at the basal rate of flow to resume. Simultaneous to the fluid delivery along flow path 35, the bolus reservoir is being filled by fluid flowing along flow path 36; however, the delivery of a bolus dose during the filling period is blocked because valve 32 is closed. The bolus reservoir is prevented from being actuated again until a predetermined lock-out period has elapsed. The dimension of restrictor tube 34 controls the fill time of bolus reservoir 30 and thus establishes the length of the lock-out period.
Valves 31 and 32 are pinch tubes formed from a pliable material, such as silicone or polyvinyl chloride (PVC) of an appropriate durometric value. Nodes 301-304 are three port connectors made of PVC or another polymer that bonds easily with the tubing sections using commonly available solvents. Restrictor tubes 33 and 34 are, for instance, glass capillaries or PVC tubes of an appropriate inner lumen. Bolus reservoir 30 is a pliable chamber formed, e.g., of two welded PVC films. The bolus reservoir is designed to store a predetermined volume of fluid that can be discharged by actuating a mechanical force onto the films (for instance, by depressing knob 51, as discussed in greater detail below).
Referring to
Referring now to
Spring 60 has three (or more, in some embodiments) rudder-like features 620, 621, 622 at the apex of its inner curved surface. The rudder-like features are spaced apart such that, when knob 51 is depressed, compressing spring 60, outside rudder-like features 620 and 622 move laterally away from the central rudder-like feature 621 (i.e., the arch between features 620 and 622 is slightly straightened). When knob 51 is sufficiently depressed, these rudder-like features come into contact with bolus reservoir 30, which is positioned below spring 60. The spreading movement of the rudder-like features creates a sweeping and squeezing effect which causes the contents of bolus reservoir 30 to be squeezed toward the edges of the reservoir and into the adjacent tubing.
Referring also to
Referring to
Valves 31 and 32 are open; that is, the leaf spring features 211 and 212 are not in contact with the spherical protrusions 510, 511, or 512 on knob 51. Because both valves are open, fluid communication between tubing sections 3022 and 3033 is allowed, as is fluid communication between tubing sections 3043 and 3034 (see
In general, infusion control device 10 is generally presented in the quick prime configuration prior to its initial use.
Referring to
In this configuration, the rudder-like features 620, 621, 622 under spring 60 are not in contact with bolus reservoir 30 until the reservoir is completely filled. Valve 31 is open, allowing fluid communication along second bolus flow path between nodes 302 and 303. The bolus reservoir is filled quickly because of the large dimension of valve 31 compared to restrictor tube 34. Valve 32 is closed by the alignment of spherical protrusion 511 with leaf spring 211, preventing outflow of fluid from the bolus reservoir during filling.
Referring to
In the ready mode configuration, fluid can flow along basal flow path 35 via restrictor tube 33; that is, infusion control device 10 constantly delivers a basal flow rate. The bolus flow paths between nodes 302 and 304 are closed. When knob 51 is depressed, valve 32 opens, allowing fluid communication between bolus reservoir 30 and output node 304. The bolus reservoir is squeezed, as described above, and the bolus dose is delivered to patient 12. After actuation of knob 51 and administration of the bolus dose, the bolus reservoir 30 is refilled via first bolus flow path 36. The dimension of restrictor tube 34 is selected to achieve a predetermined time to fill bolus reservoir 30, preventing overdosage by frequent actuations of knob 51.
In some embodiments, basal flow path 35 is not provided such that infusion control device 10 delivers fluid only upon actuation of the bolus reservoir.
It is to be understood that the foregoing description is intended to illustrate and not to limit the scope of the invention, which is defined by the scope of the appended claims. Other embodiments are within the scope of the following claims.
Patent | Priority | Assignee | Title |
Patent | Priority | Assignee | Title |
4256104, | Feb 28 1979 | Abbott Laboratories | Equipment sets and system for the sequential administration of medical liquids at dual flow rates |
5105983, | Oct 31 1989 | I-Flow Corporation | Infusion apparatus |
5304153, | Jul 10 1991 | NISSHO COPORATION | Apparatus and system for the self-dosing of a liquid medicine |
5807312, | Mar 21 1996 | Bolus pump apparatus | |
5906597, | Jun 09 1998 | CITIBANK, N A | Patient-controlled drug administration device |
6283944, | Apr 30 1998 | Medtronic, Inc | Infusion systems with patient-controlled dosage features |
6702779, | Aug 18 2000 | Becton, Dickinson and Company | Constant rate fluid delivery device with selectable flow rate and titratable bolus button |
6981967, | Jun 01 2001 | CITIBANK, N A | Large volume bolus device and method |
7559926, | Jan 13 2003 | ADVANCED NEUROMODULATION SYSTEMS, INC | Actuation system and method for an implantable infusion pump |
7618432, | Jul 18 2003 | INTERVALVE MEDICAL, INC | Valvuloplasty devices and methods |
20080257412, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Aug 26 2010 | B. Braun Melsungen AG | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Date | Maintenance Schedule |
Jul 14 2018 | 4 years fee payment window open |
Jan 14 2019 | 6 months grace period start (w surcharge) |
Jul 14 2019 | patent expiry (for year 4) |
Jul 14 2021 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jul 14 2022 | 8 years fee payment window open |
Jan 14 2023 | 6 months grace period start (w surcharge) |
Jul 14 2023 | patent expiry (for year 8) |
Jul 14 2025 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jul 14 2026 | 12 years fee payment window open |
Jan 14 2027 | 6 months grace period start (w surcharge) |
Jul 14 2027 | patent expiry (for year 12) |
Jul 14 2029 | 2 years to revive unintentionally abandoned end. (for year 12) |